Maprotiline Hydrochloride
盐酸马普替林
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameMaprotiline Hydrochloride
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1980/12/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A
Develop Information
Active CompaniesJiamusi Chenxing Pharmacy Co Ltd
Inactive CompaniesNovartis Pharma Ag
Active Indications
Inactive IndicationsN/A